FDA Inspection 1239077 — Monroe Biomedical Research
The FDA completed an inspection of Monroe Biomedical Research on May 1, 2024 in Monroe, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Monroe, NC (United States)
Additional Details
Clinical BA/BE